ClinicaliQ Trial Snapshot
- Tensi+ European Post-Market Clinical Follow-Up — Recruiting • NCT07205445.
- A study tracking how well a new electrical nerve stimulation device works for overactive bladder over one year in real clinical practice.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Tensi+ (Stimuli Technology, Boulogne Billancourt, France) is a newly released, medical transcutaneous-posterior tibial nerve stimulation (TC-pTNS) device marketed for overactive bladder (OAB) management. Preliminary studies have shown a favorable safety and efficacy profile. The goal of the present registry is to collect data among an important number of patients to assess the efficacy, safety and potential predictive factors of success in a current clinical setting over a total period of 1 year. Conditions: Overactive Bladder Interventions: Tensi+ Lead Sponsor: Stimuli Technology Planned Enrollment: 500 participants